ADVFN - Advanced Financial Network.
HOME» NYSE » G » GSK Stock Price » GSK Stock News

Glaxosmithkline Share News

 Glaxosmithkline Stock Price
GSK Stock Price
 Glaxosmithkline Stock Chart
GSK Stock Chart
 Glaxosmithkline Stock News
GSK Stock News
 Glaxosmithkline Company Information
GSK Company Information
 Glaxosmithkline Stock Trades
GSK Stock Trades

GlaxoSmithKline Buys Back 400,000 Shares

LONDON--GlaxoSmithKline PLC (GSK.LN) Monday announced it purchased 400,000 ordinary shares, to hold in treasury, on Aug. 6. MAIN FACTS: -Highest price paid per share was 1509.5 pence per share. -Lowest price paid per share was 1487 pence per share. -Shares on Monday closed at 1505 pence. -Write to Tapan Panchal at tapan.panchal@dowjones.com Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stock News for Glaxosmithkline (GSK)
DateTimeHeadline
07/23/201418:18:51ADR Shares End Mixed; GlaxoSmithKline Shares Trade Actively
07/23/201412:17:37LONDON MARKETS: Glaxo Slides In London After Earnings Warning
07/23/201410:16:22LONDON MARKETS: Glaxo Shares Fall In London After Earnings Warning
07/23/201407:50:33Genmab: 2Q Sales of Leukemia Drug Arzerra Totaled GBP12.8 Million
07/18/201418:53:06GlaxoSmithKline plc 2Q 2014 -- Forecast
07/17/201409:49:32GlaxoSmithKline: Melanoma Drug Study Shows Favorable Results
07/16/201407:14:25EUROPE MARKETS: European Stocks Jump After Strong U.K., Chinese...
07/16/201403:09:44GlaxoSmithKline Starts 3rd Phase Study Of Pulmonary Disease Treatment...
07/15/201416:49:26U.S. Hot Stocks: Hot Stocks to Watch
07/14/201418:39:18Codexis Shares Surge on GlaxoSmithKline Licensing Pact -- Update
07/14/201418:37:01Codexis in License Pact With GlaxoSmithKline
07/04/201408:07:17EU Approves Glaxo's Mekinist as Melanoma Treatment
07/03/201414:00:19ADR Shares End Higher; NQ Mobile Shares Trade Actively
07/03/201410:52:00EU Approves GlaxoSmithKline and Genmab's Leukemia Treatment
06/30/201417:04:08ADR Shares End Mixed; Philips, America Movil Trade Actively
06/30/201408:58:36Glaxo, Theravance File Asthma Drug Application with FDA
06/25/201406:45:09Glaxo Launches Phase 3 Study Into Eltrombopag Effect on MDS Sufferers
06/24/201422:00:16FDA Orders GSK to Review Its Global Manufacturing
06/24/201421:43:48FDA Orders GSK to Review Its Global Manufacturing -- Report
06/13/201403:52:48Glaxo's Phase III PETIT2 Study Meets Main Objective

Glaxosmithkline and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad